Overview Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients Status: Terminated Trial end date: 2017-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate efficacy of rhNRG-1 in reducing the death rate of heart failure. Phase: Phase 3 Details Lead Sponsor: Zensun Sci. & Tech. Co., Ltd.